Medication info

Pribrofen Injection (Ibuprofen)

Prescription medicationInjections
Ingredient · strength
Ibuprofen›400mg / 104mL
Manufacturer / importer
JW Pharmaceutical Corp.
Appearance
A clear colorless to pale yellow liquid filled in a polypropylene, multi-layer film plastic container for injection.
Packaging
104 milliliters/vial, 208 milliliters/vial
Approval status
Active

MFDS item code 202201730 · Approved 2022.04.28

Summary

Main use
Relief of moderate to severe pain (as an adjunct to opioid analgesics) and relief of fever
Who uses it
Adults · Children
Adult dosage
Administer this drug at the lowest effective dose that meets each patient's treatment goals for the shortest duration. After the initial dose, adjust the dose and frequency of administration as appropriate according to the patient's condition. This drug is a premixed formulation and must be administered as is, without dilution. Use only when one package unit per dose (ibuprofen 400mg or 800mg) can replace the required dose; do not divide the contents for use. Adults may receive up to 3200mg per day. To reduce the risk of renal adverse reactions, ensure that the patient is adequately hydrated before administration. (1) Adjunctive therapy to opioid analgesics (morphine) for the control of moderate to severe pain Adults (17 years and older): Administer 400mg-800mg intravenously every 6 hours as needed. Up to 3200mg per day may be administered. The administration time must be at least 30 minutes. (2) Fever reduction Adults (17 years and older): Administer 400mg intravenously every 4-6 hours as needed. Depending on the patient's condition, 100-200mg may also be administered every 4 hours after an initial dose of 400mg. Up to 3200mg per day may be administered. The administration time must be at least 30 minutes.
Children's dosage
6 months ~ under 12 years: Administer 10mg/kg per dose (maximum 400mg) intravenously every 4~6 hours as needed; the administration time must be at least 10 minutes. Up to 40mg/kg or 2,400mg per day may be administered (whichever is lower). 12 years and older ~ under 17 years: Administer 400mg per dose intravenously every 4~6 hours as needed; the administration time must be at least 10 minutes. Up to 2,400mg per day may be administered.

Ingredients

Manufacturer
JW Pharmaceutical Corp.

Efficacy & effects

Relief of moderate to severe pain (as an adjunct to opioid analgesics) and relief of fever

  • Moderate pain
  • severe pain
View approved original text

This medication is used to control pain ranging from moderate to severe. It is primarily administered as an adjunct to narcotic analgesics to enhance the analgesic effect and is also helpful for fever reduction. Therefore, it is effectively used for pain relief and temperature regulation.

Dosage and Administration

Adult dosage

Administer this drug at the lowest effective dose that meets each patient's treatment goals for the shortest duration. After the initial dose, adjust the dose and frequency of administration as appropriate according to the patient's condition. This drug is a premixed formulation and must be administered as is, without dilution. Use only when one package unit per dose (ibuprofen 400mg or 800mg) can replace the required dose; do not divide the contents for use. Adults may receive up to 3200mg per day. To reduce the risk of renal adverse reactions, ensure that the patient is adequately hydrated before administration. (1) Adjunctive therapy to opioid analgesics (morphine) for the control of moderate to severe pain Adults (17 years and older): Administer 400mg-800mg intravenously every 6 hours as needed. Up to 3200mg per day may be administered. The administration time must be at least 30 minutes. (2) Fever reduction Adults (17 years and older): Administer 400mg intravenously every 4-6 hours as needed. Depending on the patient's condition, 100-200mg may also be administered every 4 hours after an initial dose of 400mg. Up to 3200mg per day may be administered. The administration time must be at least 30 minutes.

Children's dosage

6 months ~ under 12 years: Administer 10mg/kg per dose (maximum 400mg) intravenously every 4~6 hours as needed; the administration time must be at least 10 minutes. Up to 40mg/kg or 2,400mg per day may be administered (whichever is lower). 12 years and older ~ under 17 years: Administer 400mg per dose intravenously every 4~6 hours as needed; the administration time must be at least 10 minutes. Up to 2,400mg per day may be administered.

Precautions

This drug should be used with caution by patients with cardiovascular diseases or risk factors, as there is an increased risk of serious cardiovascular issues such as myocardial infarction or stroke. Additionally, serious gastrointestinal adverse reactions such as gastric bleeding, ulcers, and perforation may occur, so especially elderly patients or those taking the medication for an extended period should closely monitor for these symptoms. Patients with a history of gastrointestinal ulcers or bleeding, severe liver, kidney, or heart dysfunction, and those allergic to this medication’s ingredients should not take this drug. Patients with bronchial asthma or those who have previously shown hypersensitivity to aspirin and other non-steroidal anti-inflammatory drugs should also avoid using this medication. Pregnant women in the late stages of pregnancy should refrain from taking this drug as it can harm the fetus, and caution is also needed for patients undergoing cancer treatment. This medication should be used cautiously in patients with blood disorders, liver or kidney dysfunction, hypertension, heart disease, systemic lupus erythematosus, ulcerative colitis, Crohn's disease, the elderly, pregnant women, and nursing mothers. Particularly, patients taking low-dose aspirin should consult a doctor, as this drug may reduce the efficacy of aspirin and increase the risk of gastrointestinal adverse reactions. During the use of this drug, symptoms such as severe allergic reactions, skin rashes, difficulty breathing, gastrointestinal bleeding, liver function abnormalities, and renal impairment may occur; hence, any unusual symptoms should be reported to a physician immediately. Also, do not exceed the recommended dosage or take it in conjunction with other non-steroidal anti-inflammatory drugs. Patients with hypertension or heart failure should regularly check blood pressure and fluid status when taking this medication, and close observation is required for patients with impaired renal or liver function. This drug may interact with aspirin, anticoagulants, ACE inhibitors, diuretics, lithium, methotrexate, selective serotonin reuptake inhibitors, etc., so if there are any concomitant medications, they must be disclosed. Especially after the 20th week of pregnancy, it can affect fetal kidney function, so it should only be used at minimal dosage for the shortest time necessary, and breastfeeding should be reconsidered as this medication can be passed into breast milk and affect the baby. It is advisable not to use in infants under 6 months of age as safety has not been established, and elderly patients are at increased risk of side effects due to decreased body function, requiring dosage adjustment and monitoring. In cases of overdose, severe symptoms such as dizziness, vomiting, liver function abnormalities, renal failure, and difficulty breathing can occur, and medical assistance should be sought immediately.

Side effects

Shock, anaphylactic reaction, mimic concern, chills, dyspnea, hypotension, decreased hematocrit, decreased hemoglobin, anemia, aplastic anemia, hemolytic anemia, agranulocytosis, granulocytopenia, leukopenia, thrombocytopenia, impaired platelet function, eosinophilia, peptic ulcer, gastrointestinal ulcer, gastrointestinal bleeding, perforation, ulcerative colitis, bloody stool, gastritis, pancreatitis, hematemesis, Crohn's disease, loss of appetite, nausea, vomiting, abdominal pain, dyspepsia, diarrhea, discomfort in the gastric area, upper abdominal pain, thirst, stomatitis, abdominal distension, oral ulcer, constipation, black stool, skin and mucous membrane syndrome, Stevens-Johnson syndrome, toxic epidermal necrolysis, photosensitive reaction, drug rash with eosinophilia and systemic symptoms, angioedema, bullous dermatitis, erythema multiforme, papular rash, skin redness, vesicles, rash, exfoliative dermatitis, acute generalized pustular dermatosis, hepatitis, jaundice, abnormal liver function, liver impairment, hypersensitivity, anaphylaxis, asthma attack, urticaria, eczema, purpura, rash, pruritus, asthma, bronchoconstriction, dyspnea, wheezing, scotoma, hearing loss, tinnitus, dysgeusia, dizziness, drowsiness, vertigo, depression, headache, cerebrovascular accident, irritability, aseptic meningitis, hypertension, palpitations, heart failure, myocardial infarction, angina, acute renal failure, oliguria, hematuria, proteinuria, increased serum creatinine, hyperkalemia, interstitial nephritis, nephrotic syndrome, renal papillary necrosis, decreased urine output, generalized edema, shortness of breath, lethargy, Conn's syndrome, periorbital edema, facial swelling, fatigue, fever, epistaxis, edema, peripheral edema, nausea, distension, headache, hemolysis, drowsiness, peripheral edema, urinary disturbance, anemia, decreased hemoglobin, dyspepsia, wound hemolysis, abdominal discomfort, cough, hypokalemia, eosinophilia, hypoalbuminemia, neutropenia, increased hematuria, hypernatremia, hypertension, hypoalbuminemia, hypotension, diarrhea, bacterial pneumonia, increased blood LDH, thrombocytosis, bacteremia, injection site pain, nausea, dizziness, abdominal pain, abnormal liver function, hyperkalemia, metabolic acidosis, drowsiness, loss of consciousness, seizures, renal failure, respiratory suppression

Not everyone experiences these, and they can vary from person to person.

Storage

This drug should be stored in a sealed container to prevent exposure to air, preferably at room temperature between 1 degree and 30 degrees Celsius. Proper storage maintains the effectiveness and safety of the medication.

Appearance and packaging

Appearance

A clear colorless to pale yellow liquid filled in a polypropylene, multi-layer film plastic container for injection.

Package unit

104 milliliters/vial, 208 milliliters/vial

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.